Legal Insights & Updates | Breaking News in Law & Justice

Ayble Health has been nominated for the 2026 Prix Galien USA Best Digital Health Solution — an award widely regarded as the Nobel Prize of biotechnology, judged strictly on science and patient impact.

From the beginning, Ayble has had an uncompromising commitment to clinical innovation and scientific evidence. In a digital health landscape often noisy with surface-level metrics, Ayble stood out by prioritizing methodological rigor, publishing 16 peer-reviewed studies, and proving real clinical efficacy across complex GI populations before commercializing. Their growth is a reflection of that patient-first mindset. Huge congratulations to Sam Jactel and the whole Ayble team

David Rozenblat

Aug 211 min read

SEC Reinforces Cooperation Requirements and Enforcement Priorities

The U.S. Securities and Exchange Commission (SEC) is sharpening its focus on cooperation requirements and enforcement priorities,...

David Rozenblat

Nov 4, 20245 min read

Artificial Intelligence and Inventorship Under the Patent Law Regime: Practical Developments from Common Law Jurisdictions

The emergence of Artificial Intelligence (AI) has sparked a growing debate around its role in innovation and inventorship, challenging...

David Rozenblat

Nov 4, 20245 min read

Key Developments in Patent Law So Far in 2024

Patent law in 2024 has seen significant shifts, largely influenced by advancements in technology and an evolving global landscape. These...

David Rozenblat

Nov 4, 20242 min read

Shaping Intellectual Property in the Age of AI: Emerging Challenges and Policies

As artificial intelligence (AI) progresses, it’s transforming creative and innovative processes and challenging the traditional...

David Rozenblat

Nov 4, 20243 min read